Disorders of endothelium-dependent vasodilation and oxidative stress markers in chronic kidney disease of the stage I
https://doi.org/10.24884/1682-6655-2020-19-1-29-34
Abstract
Introduction. The key point of cardiorenal relationships is the activation of the renin-angiotensin-aldosterone system and the formation of endothelial dysfunction. The aim of our study was to assess the state of endothelium-dependent vasodilation (EDVD) in patients with chronic kidney disease (CKD) as a function of the glomerular filtration rate (GFR). Materials and methods. It was investigated 40 healthy men (mean age 39.2±2.0 years) and 72 patients with CKD I st. (mean age 42.5±11.9 years). GFR was calculated using the formula CKDEPI. Tissue perfusion was studied by high-frequency ultrasound Doppler. Vascular reactivity of the skin was evaluated in functional tests with ionophoresis of acetylcholine. Results. Compared with healthy individuals, the increase in the volumetric blood flow velocity at the 2 minute test with acetylcholine was reduced only at a GFR value of 90–109 ml/min/1.73 m2, with large values of GFR, no indicator changes were detected. Also, only in these patients the most significant violations of oxidative status were noted in the form of an increase in the concentration of diene conjugates in the blood serum, a decrease in the concentration of tocopherol and general SH groups. Conclusions. Disturbance of endothelium-dependent vasodilation in the sample with acetylcholine in patients with the first stage of CKD was established with a GFR value of less than 109 ml/min/1.73 m2. Disturbance of the indicators of oxidative status was noted with a GFR value of less than 109 ml/min/1.73 m2.
About the Authors
I. Yu. Panina
Pavlov University
Russian Federation
Russian Federation
Panina Iraida Yu. – Doctor of Medical Sciences, Professor, Department of Propaedeutics of Internal Diseases
6-8 L’va Tolstogo street, Saint Petersburg, 197022
A. Sh. Rumyantsev
Pavlov University; Saint-Petersburg State University
Russian Federation
Russian Federation
Rumyantsev Alexandr Sh. – Doctor of Medical Sciences, Professor, Department of Faculty Therapy Saint-Petersburg State University; Department of Propaedeutics of Internal Diseases Pavlov University
6-8 L’va Tolstogo street, Saint Petersburg, 197022
7/9 Universitetskaya embankment, Saint Petersburg, 199034
L. V. Vasina
Pavlov University
Russian Federation
Russian Federation
Vasina Lyubov V. – Doctor of Medical Sciences, Professor, Head of the department of Biological Chemistry
6-8 L’va Tolstogo street, Saint Petersburg, 197022
E. Yu. Vasina
Pavlov University
Russian Federation
Russian Federation
Vasina Elena Yu. – PhD, Associate Professor, Department of Pathophysiology with a Course in Clinical Pathophysiology
6-8 L’va Tolstogo street, Saint Petersburg, 197022
I. M. Zubina
Pavlov University
Russian Federation
Russian Federation
Zubina Irina M. – PhD, senior researcher of the laboratory of biochemical homeostasis of the research Institute of Nephrology of the research clinical center
6-8 L’va Tolstogo street, Saint Petersburg, 197022
References
1. Kumar U, Wettersten N, Garimella PS. Cardiorenal Syndrome: Pathophysiology. Cardiol Clin. 2019;37(3):251–265. Doi: 10.1016/j.ccl.2019.04.001.
2. Rangaswami J, Soman S, McCullough PA. Key updates in Cardio-Nephrology from 2018: springboard to a bright Future. Rev Cardiovasc Med. 2018;19(4):113–116. Doi: 10.31083/j.rcm.2018.04.896.
3. Vlasov TD, Nesterovich II, Shimanski DA. Endothelial dysfunction: from the particular to the general. Return to the «Old Paradigm»? Regional blood circulation and microcirculation. 2019;18(2):19–27. (In Russ.). Doi: 10.24884/1682-6655-2019-18-2-19-27.
4. Smirnov AV, Petrishchev NN, Mnuskina MM et al. Endothelial dysfunction and apoptosis in the early stages of chronic kidney disease. Therapeutic Archive. 2012;84(6):9–15. (In Russ.).
5. Goligorsky MS. Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold. Kidney Res Clin Pract. 2015;34(2):76–82. Doi: 10.1016/j.krcp.2015.05.003.
6. Rodin R, Chan CT. Determinants and Prevention of Coronary Disease in Patients With Chronic Kidney Disease. Can J Cardiol. 2019;35(9):1181–1187. Doi: 10.1016/j.cjca.2019.05.025.
7. Ballew SH, Matsushita K. Cardiovascular Risk Prediction in CKD. Semin Nephrol. 2018;38(3):208–216. Doi: 10.1016/j.semnephrol.2018.02.002.
8. van der Velde M, Matsushita K, Coresh J et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79(12):1341–1352.
9. Kovesdy CP, Bleyer AJ, Molnar MZ et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med. 2013;159(4):233–242 Doi: 10.7326/0003-4819-159-4-201308200-00004.
10. Afsar B, Turkmen K, Covic A, Kanbay M. An update on coronary artery disease and chronic kidney disease. Int J Nephrol. 2014;2014:767424. Doi: 10.1155/2014/767424.
11. Oh SW, Kim S, Na KY et al. Glomerular filtration rate and proteinuria: association with mortality and renal progression in a prospective cohort of a community-based elderly population. PLoS One. 2014;9(4):e94120. Doi: 10.1371/journal.pone.0094120.
12. Smirnov AV, Petrishchev NN, Panina IYu et al. The importance of annexin A5 in assessing the severity of endothelial dysfunction in the preclinical stage of atherosclerosis in patients with chronic kidney disease. Nephrology. 2005;9(4):41–46. (In Russ.). Doi: 10.24884/1561-6274-2005-9-4-41-45.
13. Petrishchev NN, Smirnov AV, Panina IYu et al. Arterial hypertension and endothelial dysfunction in chronic kidney disease. Arterial hypertension. 2006;12(4):352–357. (In Russ.).
14. Panina IYu, Rumyantsev ASh, Menshutina MA et al. Features of endothelial function in chronic kidney disease. Literature review and own data. Nephrology. 2007;11(4):28–46. (In Russ.). Doi: 10.18705/1607-419X-2006-12-4-352-357.
15. Emmanuel VL, Mnuskina MM, Smirnov AV et al. Annexin-5 is a biochemical marker of early vascular disorders in chronic kidney disease. Clinical Laboratory Diagnostics. 2013;(4):9–10. (In Russ.).
16. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
17. Petrishchev NN, Smirnov AV, Panina IYu et al. Non-invasive methods for assessing the vasomotor form of endothelial dysfunction in patients with chronic kidney disease. Regional blood circulation and microcirculation. 2005;15(3):62–66. (In Russ.).
18. Smirnov AV, Petrishchev NN, Panina IYu et al. Glomerular filtration rate – an indicator of the functional state of the endothelium in the early stages of the development of chronic kidney disease. Therapeutic Archive. 2007;79(6):25–30. (In Russ.).
19. Caglar K, Yilmaz MI, Sonmez A et al. ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney Int. 2006;70(4):781–787.
20. Schwedhelm E, Böger RH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol. 2011;7(5):275–285. Doi: 10.1038/nrneph.2011.31.
21. Raptis V, Kapoulas S, Grekas D. Role of asymmetrical dimethylarginine in the progression of renal disease. Nephrology (Carlton). 2013;18(1):11–21. Doi: 10.1111/j.14401797.2012.01659.x.
Review
For citations:
Panina I.Yu., Rumyantsev A.Sh., Vasina L.V., Vasina E.Yu., Zubina I.M. Disorders of endothelium-dependent vasodilation and oxidative stress markers in chronic kidney disease of the stage I. Regional blood circulation and microcirculation. 2020;19(1):29-34. (In Russ.) https://doi.org/10.24884/1682-6655-2020-19-1-29-34
Views:
1494
Email this article 
